Cancer genes and the pathways they control (Q28275089)

Mutations of the BRAF gene in human cancer

Europe PubMed Central

title

Cancer genes and the pathways they control (English)

0 references

1

Bert Vogelstein

0 references

Kenneth W. Kinzler

series ordinal

2

object named as

Kenneth W Kinzler

0 references

language of work or name

English

0 references

publication date

August 2004

0 references

published in

Nature Medicine

0 references

volume

10

0 references

issue

8

0 references

page(s)

789-99

0 references

cites work

1 reference

https://api.crossref.org/works/10.1038/NM1087

Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NM1087

21 April 2017

Surfing the p53 network

1 reference

https://api.crossref.org/works/10.1038/NM1087

Targeting HIF-1 for cancer therapy

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NM1087

Genetic instabilities in human cancers

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NM1087

In search of the tumour-suppressor functions of BRCA1 and BRCA2

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NM1087

MutS homologs in mammalian cells

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NM1087

Worms gang up on bacteria

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NM1087

A vision for the future of genomics research

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NM1087

A large-scale RNAi screen in human cells identifies new components of the p53 pathway

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NM1087

A census of human cancer genes

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NM1087

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NM1087

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NM1087

Lessons from hereditary colorectal cancer

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NM1087

Targeting RAS signalling pathways in cancer therapy

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NM1087

The phosphoinositide 3-kinase pathway

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NM1087

Mechanisms of TGF-beta signaling from cell membrane to the nucleus

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NM1087

A role for mitochondrial enzymes in inherited neoplasia and beyond

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NM1087

The Hedgehog response network: sensors, switches, and routers

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NM1087

Signal Transduction and the Control of Gene Expression

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NM1087

Dissemination and growth of cancer cells in metastatic sites

21 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FNM1087

Signaling--2000 and beyond

21 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FNM1087

Role of angiogenesis in tumor growth and metastasis

21 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FNM1087

Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer

21 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FNM1087

Exploring the new world of the genome with DNA microarrays

21 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FNM1087

The history of cancer epigenetics

21 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FNM1087

21 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FNM1087

7 January 2021

DNA damage and repair

1 reference

https://api.crossref.org/works/10.1038%2FNM1087

7 January 2021

Tumor progression: a brief historical perspective

1 reference

https://api.crossref.org/works/10.1038%2FNM1087

7 January 2021

Selectively advantageous mutations and hitchhikers in neoplasms: p16 lesions are selected in Barrett's esophagus

1 reference

https://api.crossref.org/works/10.1038%2FNM1087

7 January 2021

Cancer modeling in the modern era: progress and challenges

1 reference

https://api.crossref.org/works/10.1038%2FNM1087

7 January 2021

Worms, life, and death (Nobel lecture).

1 reference

https://api.crossref.org/works/10.1038%2FNM1087

7 January 2021

The retinoblastoma tumour suppressor in development and cancer

1 reference

https://api.crossref.org/works/10.1038%2FNM1087

7 January 2021

Decision making by p53: life, death and cancer

1 reference

https://api.crossref.org/works/10.1038%2FNM1087

7 January 2021

Perspectives in studies of human tumor viruses

1 reference

https://api.crossref.org/works/10.1038%2FNM1087

7 January 2021

Human papillomavirus immortalization and transformation functions

1 reference

https://api.crossref.org/works/10.1038%2FNM1087

7 January 2021

Oncogenic DNA viruses

1 reference

https://api.crossref.org/works/10.1038%2FNM1087

7 January 2021

Mutation-selection networks of cancer initiation: tumor suppressor genes and chromosomal instability.

1 reference

https://api.crossref.org/works/10.1038%2FNM1087

7 January 2021

The critical role of chromosome translocations in human leukemias.

1 reference

https://api.crossref.org/works/10.1038%2FNM1087

7 January 2021

Are tumours angiogenesis-dependent?

1 reference

https://api.crossref.org/works/10.1038%2FNM1087

7 January 2021

Know thy neighbor: stromal cells can contribute oncogenic signals

1 reference

https://api.crossref.org/works/10.1038%2FNM1087

7 January 2021

Regulation of mammary gland branching morphogenesis by the extracellular matrix and its remodeling enzymes

1 reference

https://api.crossref.org/works/10.1038%2FNM1087

7 January 2021

Clinical translation of angiogenesis inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FNM1087

7 January 2021

Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein

1 reference

https://api.crossref.org/works/10.1038%2FNM1087

7 January 2021

Sequence-based cancer genomics: progress, lessons and opportunities

1 reference

https://api.crossref.org/works/10.1038%2FNM1087

7 January 2021

Multiple mutations and cancer

1 reference

https://api.crossref.org/works/10.1038%2FNM1087

7 January 2021

The significance of unstable chromosomes in colorectal cancer.

1 reference

https://api.crossref.org/works/10.1038%2FNM1087

7 January 2021

Genomic instability--the engine of tumorigenesis?

1 reference

https://api.crossref.org/works/10.1038%2FNM1087

7 January 2021

Prevalence of somatic alterations in the colorectal cancer cell genome

1 reference

https://api.crossref.org/works/10.1038%2FNM1087

7 January 2021

Genomic microarrays in human genetic disease and cancer

1 reference

https://api.crossref.org/works/10.1038%2FNM1087

7 January 2021

ATM: genome stability, neuronal development, and cancer cross paths

1 reference

https://api.crossref.org/works/10.1038%2FNM1087

7 January 2021

Connecting chromosomes, crisis, and cancer

1 reference

https://api.crossref.org/works/10.1038%2FNM1087

7 January 2021

Mutations and aneuploidy: co-conspirators in cancer?

1 reference

https://api.crossref.org/works/10.1038%2FNM1087

7 January 2021

Inactivation of hCDC4 can cause chromosomal instability

1 reference

https://api.crossref.org/works/10.1038%2FNM1087

7 January 2021

Hallmarks of senescence in carcinogenesis and cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FNM1087

7 January 2021

Critical determinants of metastasis

1 reference

https://api.crossref.org/works/10.1038%2FNM1087

7 January 2021

Host genetics and tumour metastasis

1 reference

https://api.crossref.org/works/10.1038%2FNM1087

7 January 2021

Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNM1087

7 January 2021

Aberrant crypt foci and K-ras mutations: earliest recognized players or innocent bystanders in colon carcinogenesis?

1 reference

https://api.crossref.org/works/10.1038%2FNM1087

7 January 2021

In ovarian neoplasms, BRAF, but not KRAS, mutations are restricted to low-grade serous tumours

1 reference

https://api.crossref.org/works/10.1038%2FNM1087

7 January 2021

https://api.crossref.org/works/10.1038%2FNM1087

1 reference

7 January 2021

Wildtype Kras2 can inhibit lung carcinogenesis in mice

1 reference

https://api.crossref.org/works/10.1038%2FNM1087

7 January 2021

Development. Making sense of the sensory lineage

1 reference

https://api.crossref.org/works/10.1038%2FNM1087

7 January 2021

Eukaryotic mismatch repair: an update

1 reference

https://api.crossref.org/works/10.1038%2FNM1087

7 January 2021

Hereditary colorectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FNM1087

7 January 2021

Gastrointestinal cancer of the microsatellite mutator phenotype pathway

1 reference

https://api.crossref.org/works/10.1038%2FNM1087

7 January 2021

Genomic instability in neoplasia.

1 reference

https://api.crossref.org/works/10.1038%2FNM1087

7 January 2021

Gene discovery using the serial analysis of gene expression technique: implications for cancer research

1 reference

https://api.crossref.org/works/10.1038%2FNM1087

7 January 2021

The fundamental role of epigenetic events in cancer

1 reference

https://api.crossref.org/works/10.1038%2FNM1087

7 January 2021

A new paradigm for drug discovery: integrating clinical, genetic, genomic and molecular phenotype data to identify drug targets

1 reference

https://api.crossref.org/works/10.1038%2FNM1087

7 January 2021

A resource for large-scale RNA-interference-based screens in mammals.

1 reference

https://api.crossref.org/works/10.1038%2FNM1087

7 January 2021

Serum proteomics in cancer diagnosis and management.

1 reference

https://api.crossref.org/works/10.1038%2FNM1087

7 January 2021

Looking beyond morphology: cancer gene expression profiling using DNA microarrays

1 reference

https://api.crossref.org/works/10.1038%2FNM1087

7 January 2021

A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen

1 reference

https://api.crossref.org/works/10.1038%2FNM1087

7 January 2021

Gene expression alterations over large chromosomal regions in cancers include multiple genes unrelated to malignant progression

1 reference

https://api.crossref.org/works/10.1038%2FNM1087

7 January 2021

Senescence: does it all happen at the ends?

1 reference

https://api.crossref.org/works/10.1038%2FNM1087

7 January 2021

Telomere dysfunction and the initiation of genome instability.

1 reference

https://api.crossref.org/works/10.1038%2FNM1087

7 January 2021

Telomeres and telomerase

1 reference

https://api.crossref.org/works/10.1038%2FNM1087

7 January 2021

Beginning to understand the end of the chromosome

1 reference

https://api.crossref.org/works/10.1038%2FNM1087

7 January 2021

Microarray reality checks in the context of a complex disease

1 reference

https://api.crossref.org/works/10.1038%2FNM1087

7 January 2021

Human acute myeloid leukemia stem cells

1 reference

https://api.crossref.org/works/10.1038%2FNM1087

7 January 2021

Reconstruction of functionally normal and malignant human breast tissues in mice

1 reference

https://api.crossref.org/works/10.1038%2FNM1087

7 January 2021

The molecular and cellular biology of HER2/neu gene amplification/overexpression and the clinical development of herceptin (trastuzumab) therapy for breast cancer.

1 reference

https://api.crossref.org/works/10.1038%2FNM1087

7 January 2021

Gastrointestinal stromal tumours and their response to treatment with the tyrosine kinase inhibitor imatinib

1 reference

https://api.crossref.org/works/10.1038%2FNM1087

7 January 2021

Emerging role of epidermal growth factor receptor inhibition in therapy for advanced malignancy: focus on NSCLC.

1 reference

https://api.crossref.org/works/10.1038%2FNM1087

7 January 2021

Biology of gastrointestinal stromal tumors: KIT mutations and beyond

1 reference

https://api.crossref.org/works/10.1038%2FNM1087

7 January 2021

Cell death: critical control points

1 reference

https://api.crossref.org/works/10.1038%2FNM1087

7 January 2021

Apoptosis: mediator or mode of cell killing by anticancer agents?

1 reference

https://api.crossref.org/works/10.1038%2FNM1087

7 January 2021

Overview of the clinical efficacy of investigational anticancer drugs

1 reference

https://api.crossref.org/works/10.1038%2FNM1087

7 January 2021

Heterogeneous patterns of FLT3 Asp(835) mutations in relapsed de novo acute myeloid leukemia: a comparative analysis of 120 paired diagnostic and relapse bone marrow samples

1 reference

https://api.crossref.org/works/10.1038%2FNM1087

7 January 2021

Shedding light onto live molecular targets

1 reference

https://api.crossref.org/works/10.1038%2FNM1087

7 January 2021

Emerging molecular markers of cancer.

1 reference

https://api.crossref.org/works/10.1038%2FNM1087

7 January 2021

The discovery of receptor tyrosine kinases: targets for cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FNM1087

7 January 2021

To cycle or not to cycle: a critical decision in cancer.

1 reference

https://api.crossref.org/works/10.1038%2FNM1087

7 January 2021

Hedgehog--Gli signaling in brain tumors: stem cells and paradevelopmental programs in cancer

1 reference

https://api.crossref.org/works/10.1038%2FNM1087

7 January 2021

Ways of dying: multiple pathways to apoptosis.

1 reference

https://api.crossref.org/works/10.1038%2FNM1087

7 January 2021

Cell metabolism in the regulation of programmed cell death

1 reference

https://api.crossref.org/works/10.1038%2FNM1087

7 January 2021

A matter of life and death

1 reference

https://api.crossref.org/works/10.1038%2FNM1087

7 January 2021

The Runx genes: lineage-specific oncogenes and tumor suppressors

1 reference

https://api.crossref.org/works/10.1038%2FNM1087

7 January 2021